WELCOME MESSAGE FROM THE ORGANIZERS
We extend a warm welcome to the distinguished Nobel laureates, speakers, delegates, biotechnologists and pharmaceutical industry leaders, from around the world to the USA, for attending Global Biotechnology Congress (GBC 2015).
This event will focus on various important disciplines of biotechnology and its applications for improvement in health and quality of life the world over. It is anticipated that up to 1000 of the world's leading scientists, researchers, industrialists and academicians, including several Nobel Laureates, in the fields of biotechnology and medical and biological sciences, will attend this forum, in Boston, to share and discuss new scientific ideas, products and breakthroughs. We are indeed pleased to host such an international conference in the United States of America.
This conference will have a variety of lectures from eminent scientists, including Noble Laureates, who will deliver lectures on plant and environmental technologies, transgenic plants and crops, bioremediation, microbial diversity and bio-monitoring. Focus will be given to medical biotechnology, stem cells, gene therapy, tissue engineering, bio-pharmaceutical manufacturing, cell based therapy, cell cultivation, diagnostics, imaging, pharmacogenomics, microarray technology, biomarkers, pharmaceutical biotechnology, vaccines, CNS, Cancer, antibodies, protein engineering. There will also be important lectures on food, marine, bio-safety systems biology, clinical reserved/clinical trials, bioethics and Nano biotechnology.
We hope that the deliberations and recommendations of this conference will have a significant impact on the future directions of business development, strategic alliances, partnering trends, product opportunities, growth, business models and strategies, licensing merger and acquisitions, outsourcing, venture capital and financing and intellectual property.
Nobel Laureate Ferid Murad, M.D. is Director Emeritus of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, Director of the IMM Center for Cell Signaling, Regental Professor, John S. Dunn, Sr. Distinguished Chair in Physiology and Medicine, Texas Nobel Scholar at the University of Texas at Houston, and Director of the UT Health Science Center at Houston Program in Intracellular Signaling.
Dr. Murad completed his undergraduate work at DePauw University and received his M.D. and Ph.D. from Case Western Reserve University. He had a medical residency at Massachusetts General Hospital and a fellowship at NIH in the Heart Institute. He was on the faculty at the University of Virginia 1970-81 as Director of the Clinical Research Center and Director of the Division of Clinical Pharmacology with appointments in Medicine and Pharmacology. He was Chief of Medicine at Palo Alto Veterans Hospital 1981-88, Associate Chairman of Medicine 1982-86 and Chairman of Medicine 1986-88 at Stanford University. He was Vice President of Research and Development at Abbott Laboratories 1988-93 and Professor at Northwestern University.
Dr. Murad has been active in both academic medicine and industry throughout his distinguished career. He has founded or co-founded five biotechnology companies and has advised many cities and government leaders about technology development. His work has concentrated on the field of cell signaling and signal transduction systems.
In 1998, Dr. Murad received the Nobel Prize in Medicine for his work with nitric oxide – a colorless, odorless gas that signals blood vessels to relax and widen, which in turn lowers blood pressure. He continues research which leads to a better understanding of how information is transmitted between cells.
Among his many other awards and honors, Dr. Murad received the prestigious Albert and Mary Lasker Basic Medical Research Award in 1996, the American Heart Association Ciba Award in 1988, and the Baxter Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2000. He also received the American Society of Clinical Pharmacology Distinguished Research Prize in 2005 and the President’s Scholar Award from the University of Texas-Houston Health Science Center in 2006.
He is a member of the National Academy of Sciences, Institute of Medicine of the National Academy of Sciences, Fellow of the American Academy of Arts and Sciences, Texas Academy of Medicine, and Engineering and Science Technology. He is also a member of several foreign academies and is an Honorary or Adjunct Professor at a number of universities. Dr. Murad also serves on the Board of Directors and Scientific Advisory Boards of a number of public and private companies and various foundations and universities. About 140 trainees have worked in his laboratories who are currently academic or pharmaceutical industry leaders around the world.